Cargando…

Diet-induced metabolic hamster model of nonalcoholic fatty liver disease

BACKGROUND: Obesity, hypercholesterolemia, elevated triglycerides, and type 2 diabetes are major risk factors for metabolic syndrome. Hamsters, unlike rats or mice, respond well to diet-induced obesity, increase body mass and adiposity on group housing, and increase food intake due to social confron...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bhathena, Jasmine, Kulamarva, Arun, Martoni, Christopher, Urbanska, Aleksandra Malgorzata, Malhotra, Meenakshi, Paul, Arghya, Prakash, Satya
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2011
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3131800/ https://www.ncbi.nlm.nih.gov/pubmed/21760736 http://dx.doi.org/10.2147/DMSO.S18435

Ejemplares similares

Oral Probiotic Microcapsule Formulation Ameliorates Non-Alcoholic Fatty Liver Disease in Bio F(1)B Golden Syrian Hamsters
por: Bhathena, Jasmine, et al.
Publicado: (2013)

Erratum to “Suppression of Tumorigenesis: Modulation of Inflammatory Cytokines by Oral Administration of Microencapsulated Probiotic Yogurt Formulation”
por: Urbanska, Aleksandra Malgorzata, et al.
Publicado: (2011)

Oral Microencapsulated Live Saccharomyces cerevisiae Cells for Use in Renal Failure Uremia: Preparation and In Vivo Analysis
por: Coussa, Razek, et al.
Publicado: (2010)

Investigation of Microencapsulated BSH Active Lactobacillus in the Simulated Human GI Tract
por: Martoni, Christopher, et al.
Publicado: (2007)

Erratum of “Investigation of Microencapsulated BSH Active Lactobacillus in the Simulated Human GI Tract”
por: Martoni, Christopher, et al.
Publicado: (2009)

Suppression of Tumorigenesis: Modulation of Inflammatory Cytokines by Oral Administration of Microencapsulated Probiotic Yogurt Formulation
por: Urbanska, Aleksandra Malgorzata, et al.
Publicado: (2010)

Human serum albumin nanoparticles as an efficient noscapine drug delivery system for potential use in breast cancer: preparation and in vitro analysis
por: Sebak, Safaa, et al.
Publicado: (2010)

Mediterranean diet and nonalcoholic fatty liver disease
por: Anania, Caterina, et al.
Publicado: (2018)

Diet and Lifestyle in Nonalcoholic Fatty Liver Disease
por: Martínez-Beamonte, Roberto, et al.
Publicado: (2020)

Dysregulated Hepatic Methionine Metabolism Drives Homocysteine Elevation in Diet-Induced Nonalcoholic Fatty Liver Disease
por: Pacana, Tommy, et al.
Publicado: (2015)

Colon-targeted delivery of live bacterial cell biotherapeutics including microencapsulated live bacterial cells
por: Prakash, Satya, et al.
Publicado: (2008)

Vegetarian diet, food substitution, and nonalcoholic fatty liver
por: Chiu, Tina H., et al.
Publicado: (2018)

Zerumbone, a Natural Cyclic Sesquiterpene of Zingiber zerumbet Smith, Attenuates Nonalcoholic Fatty Liver Disease in Hamsters Fed on High-Fat Diet
por: Tzeng, Thing-Fong, et al.
Publicado: (2013)

The Development of Nonalcoholic Fatty Liver Disease and Metabolic Syndromes in Diet-Induced Rodent Models
por: Aljahdali, Bayan Abdulhafid, et al.
Publicado: (2023)

Lipoprotein metabolism in nonalcoholic fatty liver disease
por: Jiang, Zhenghui Gordon, et al.
Publicado: (2013)

Metabolic Targets in Nonalcoholic Fatty Liver Disease
por: Esler, William P., et al.
Publicado: (2019)

Macrophage metabolism in nonalcoholic fatty liver disease
por: Zhang, Wenhui, et al.
Publicado: (2023)

Editorial: Metabolism in nonalcoholic fatty liver disease
por: Najjar, Sonia Michael, et al.
Publicado: (2023)

Dietary Supplementation with Hazelnut Oil Reduces Serum Hyperlipidemia and Ameliorates the Progression of Nonalcoholic Fatty Liver Disease in Hamsters Fed a High-Cholesterol Diet
por: Lu, Jen-Her, et al.
Publicado: (2019)

Temporal Development of Dyslipidemia and Nonalcoholic Fatty Liver Disease (NAFLD) in Syrian Hamsters Fed a High-Fat, High-Fructose, High-Cholesterol Diet
por: Svop Jensen, Victoria, et al.
Publicado: (2021)

Corrigendum: Vegetarian diet, food substitution, and nonalcoholic fatty liver
Publicado: (2018)

Retraction: Nonalcoholic fatty liver disease, diet and gut microbiota
por: Finelli, Carmine, et al.
Publicado: (2017)

Gut Microbial Metabolism and Nonalcoholic Fatty Liver Disease
por: Sharpton, Suzanne R., et al.
Publicado: (2018)

An Overview of Lipid Metabolism and Nonalcoholic Fatty Liver Disease
por: Pei, Ke, et al.
Publicado: (2020)

IMM‐H007, a new therapeutic candidate for nonalcoholic fatty liver disease, improves hepatic steatosis in hamsters fed a high‐fat diet
por: Shi, Huijie, et al.
Publicado: (2017)

Nonalcoholic fatty liver disease as a metabolic disease in humans: A literature review
por: Cariou, Bertrand, et al.
Publicado: (2021)

Update cognition of nonalcoholic fatty liver disease/metabolism‐associated fatty liver disease
por: Gu, Weijun, et al.
Publicado: (2022)

Dataset for liver metabolomic profile of highland barley Monascus purpureus went extract-treated golden hamsters with nonalcoholic fatty liver disease
por: Zhu, Mei-Ning, et al.
Publicado: (2021)

Effect of a ketogenic diet on hepatic steatosis and hepatic mitochondrial metabolism in nonalcoholic fatty liver disease
por: Luukkonen, Panu K., et al.
Publicado: (2020)

Calorie-Restricted Mediterranean and Low-Fat Diets Affect Fatty Acid Status in Individuals with Nonalcoholic Fatty Liver Disease
por: Ristic-Medic, Danijela, et al.
Publicado: (2020)

The transcontinental variability of nonalcoholic fatty liver disease
por: Oliveira, Claudia P., et al.
Publicado: (2020)

Nonalcoholic Fatty Liver Disease
por: Filipović, Branka, et al.
Publicado: (2018)

Nonalcoholic fatty liver disease
por: Bebawi, Emmanuel, et al.
Publicado: (2023)

The Influence of Metabolic Factors for Nonalcoholic Fatty Liver Disease in Women
por: Chung, Goh Eun, et al.
Publicado: (2015)

Metabolic causes and consequences of nonalcoholic fatty liver disease (NAFLD)
por: Zarghamravanbakhsh, Paria, et al.
Publicado: (2021)

Frailty in metabolic syndrome, focusing on nonalcoholic fatty liver disease
por: Karakousis, Nikolaos D., et al.
Publicado: (2022)

Dysregulation of Lipid and Glucose Metabolism in Nonalcoholic Fatty Liver Disease
por: Bhat, Neha, et al.
Publicado: (2023)

Metabolic and Hepatic Effects of Empagliflozin on Nonalcoholic Fatty Liver Mice
por: Niu, Shu, et al.
Publicado: (2023)

Identification of metabolic biomarkers associated with nonalcoholic fatty liver disease
por: Jiang, Hua, et al.
Publicado: (2023)

Gypenosides ameliorate high-fat diet-induced nonalcoholic fatty liver disease in mice by regulating lipid metabolism
por: Zhou, Tingting, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_6paojisufsnqk6cgdaf0uvj2gh